Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Breakthrough BleedingBreakthrough Spotting
Interventions
OTHER

remove ring if bleeding or spotting occurs more than 5 days

Both groups of women will be using the nuvaring continuously, ie if the ring is placed on 3rd of January, on the 3rd of February the ring would be removed and a new one inserted. On the 3rd of March the same thing would happen and so forth. Group 2 if bleeding or spotting occurs for more than 5 days then on the 6th day the ring is removed and will keep it out for three more days and reinsert the same ring on the 4th day.

OTHER

If bleeding does not remove ring

Subject is using the nuvaring continuously. For example she puts the ring in on 3rd of January then the 3rd of February is when that ring is removed and another one is inserted. The 3rd of March the same thing occurs.

Trial Locations (1)

76508

Scott & White Hospital and Clinic, Temple

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Organon

INDUSTRY

lead

Scott and White Hospital & Clinic

OTHER

NCT00475553 - Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing® | Biotech Hunter | Biotech Hunter